public cord blood banks in india
Reliance Life Sciences Ushers Stem Cell Technology
Magic is how most people who are suffering from myriad haematological diseases describe Stem Cell Technology. Till a decade ago, the potential of stem cells was undiscovered. Nobody was aware of how miraculously these stem cells can treat a number of diseases. Reliance Group which has always been pioneering experimental ventures in various fields has once again come forward in the field of Stem Cell Technology.
Stem Cells are basically tiny cells in our body and as the name itself denotes all other cells are born out of these cells. These cells are responsible for growing, clubbing and for making various body parts like heart, spine, brain, muscles, skin, limbs and including others. Once the body has fully grown, these cells take refuge in the marrow of the bones, under the nose, in the stomach, and in the eye cavities including other places till the time they are again required to make for tissues or organs. These stem cells work like repair systems for our body, a store house of mechanics with the power to renew the body.
Till a decade ago, this unbelievable power of stem cells was far from being known to people. Many researches and experiments later, the mysteries of these super small stem cells have been unveiled. This has brought on a revolution in the field of treatment of a number of diseases including many grave eye diseases.
Speaking about Allergic Conjunctivitis one such eye problem, Mohit Verma who is in his early 20s tells about his ordeal with the disease which had made him lose his eyesight. He adds that his long fight with the disease met its end when he finally underwent stem cell treatment. Now he can see properly and happily credits the stem cell treatment for his new life.
Reliance Life Sciences’ first cord blood repository has been set up in South Asia. The cord blood program allows for the Stem Cell enriched cord blood repository services and enriched cord blood for the transplantation to cure blood disorders. The repository is open to both public as well as to the family banking services. Moreover, free HLA search is also offered to the patients. Reliance Life Sciences cord blood repository has more than 5,000 units and holds the credit of being the first ever cord blood repository in the world which has been approved with a license by Food and Drug Administration, an official Government of India regulatory authority.
About the Author
Reliance Life Sciences, biotech-initiative of Mukesh Ambani’s Reliance Group, is a research-driven, biotechnology-led, life sciences organization.